• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

塞来昔布对人卵巢癌细胞的凋亡作用取决于p53状态。

Apoptotic effect of celecoxib dependent upon p53 status in human ovarian cancer cells.

作者信息

Song Yoo-Cheol, Kim Su-Hyeong, Juhnn Yong-Sung, Song Yong-Sang

机构信息

Department of Obstetrics and Gynecology, Seoul National University College of Medicine, 28 Yongun-dong, Chongno-gu, Seoul, 110-744, Korea.

出版信息

Ann N Y Acad Sci. 2007 Jan;1095:26-34. doi: 10.1196/annals.1397.004.

DOI:10.1196/annals.1397.004
PMID:17404014
Abstract

Celecoxib, a selective cyclooxygenase-2 (COX-2) inhibitor, induces the apoptosis in various cancers in COX-2 dependent and/or independent manners. The p53 protein is mutated in 50% of all human tumors and plays a key role in apoptosis, cell cycle, and the expression of several proteins. In ovarian cancer, the rate of p53 mutation has been shown to be very high and associated with poor prognosis. To explore the importance of functional status of p53 in apoptosis by celecoxib in ovarian cancer cells, the cellular response to celecoxib was determined in SK-OV3 ovarian cancer cells with null type p53 and PA-1 with wild-type p53. Our results showed that celecoxib inhibited cell growth more in PA-1 than in SK-OV3. The underlying antiproliferative mechanism may differ between these two cell types dependent upon the functional status of p53, which plays integral roles in regulating cell cycle and survival. Higher sub-G1 was shown in PA-1 than in SK-OV3 in response to celecoxib (PA-1 versus SK-OV3; 60.28% versus 6.69%). Caspase -8, -9, and -3 were activated in PA-1 cells, but not in SK-OV3 cells. These results suggest that death receptor and mitochondria-mediated apoptotic pathways may be involved in celecoxib-induced apoptosis dependent upon the functional status of p53. Our article demonstrated that the celecoxib effectively inhibited cell growth and induced apoptosis in human ovarian cancer cells with wild-type p53. Thus, apoptotic effect by celecoxib seemed to be different dependent upon the functional status of p53.

摘要

塞来昔布是一种选择性环氧化酶-2(COX-2)抑制剂,以COX-2依赖和/或独立的方式诱导多种癌症细胞凋亡。p53蛋白在所有人类肿瘤中有50%发生突变,在细胞凋亡、细胞周期以及几种蛋白质的表达中起关键作用。在卵巢癌中,p53突变率很高且与预后不良相关。为了探究p53功能状态在塞来昔布诱导卵巢癌细胞凋亡中的重要性,我们在p53基因缺失的SK-OV3卵巢癌细胞和p53基因野生型的PA-1细胞中测定了细胞对塞来昔布的反应。我们的结果显示,塞来昔布对PA-1细胞生长的抑制作用比对SK-OV3细胞更强。这两种细胞类型潜在的抗增殖机制可能因p53的功能状态不同而有所差异,p53在调节细胞周期和细胞存活中起着不可或缺的作用。与塞来昔布作用后,PA-细胞中出现更高比例的亚G1期细胞(PA-1与SK-OV3相比;60.28%对6.69%)。PA-1细胞中半胱天冬酶-8、-9和-3被激活,而SK-OV3细胞中未激活。这些结果表明,死亡受体和线粒体介导的凋亡途径可能参与了塞来昔布诱导的、依赖于p53功能状态的细胞凋亡。我们的研究表明,塞来昔布能有效抑制具有野生型p53的人卵巢癌细胞的生长并诱导其凋亡。因此,塞来昔布的凋亡作用似乎因p53的功能状态不同而有所差异。

相似文献

1
Apoptotic effect of celecoxib dependent upon p53 status in human ovarian cancer cells.塞来昔布对人卵巢癌细胞的凋亡作用取决于p53状态。
Ann N Y Acad Sci. 2007 Jan;1095:26-34. doi: 10.1196/annals.1397.004.
2
Celecoxib induces p53-PUMA pathway for apoptosis in human colorectal cancer cells.塞来昔布通过诱导p53-PUMA通路促使人大肠癌细胞凋亡。
Chem Biol Interact. 2008 Oct 22;176(1):48-57. doi: 10.1016/j.cbi.2008.07.012. Epub 2008 Aug 8.
3
Time-dependent changes in factors involved in the apoptotic process in human ovarian cancer cells as a response to cisplatin.人卵巢癌细胞凋亡过程中相关因子随时间的变化作为对顺铂的反应
Gynecol Oncol. 2002 Mar;84(3):404-12. doi: 10.1006/gyno.2001.6537.
4
Role of p53 in G2/M cell cycle arrest and apoptosis in response to gamma-irradiation in ovarian carcinoma cell lines.p53在卵巢癌细胞系中γ射线照射诱导的G2/M期细胞周期阻滞和凋亡中的作用
Int J Oncol. 2003 Jan;22(1):51-7.
5
Potent cell growth inhibitory effects in hepatitis B virus X protein positive hepatocellular carcinoma cells by the selective cyclooxygenase-2 inhibitor celecoxib.选择性环氧化酶-2抑制剂塞来昔布对乙型肝炎病毒X蛋白阳性肝癌细胞具有强大的细胞生长抑制作用。
Mol Carcinog. 2009 Jan;48(1):56-65. doi: 10.1002/mc.20455.
6
Celecoxib, a cyclooxygenase-2 inhibitor, induces apoptosis in human osteosarcoma cell line MG-63 via down-regulation of PI3K/Akt.塞来昔布,一种环氧化酶-2抑制剂,通过下调PI3K/Akt诱导人骨肉瘤细胞系MG-63凋亡。
Cell Biol Int. 2008 May;32(5):494-501. doi: 10.1016/j.cellbi.2007.10.008. Epub 2007 Nov 5.
7
Oncolytic herpes simplex virus-1 lacking ICP34.5 induces p53-independent death and is efficacious against chemotherapy-resistant ovarian cancer.缺失ICP34.5的溶瘤单纯疱疹病毒-1可诱导不依赖p53的细胞死亡,对化疗耐药的卵巢癌有效。
Clin Cancer Res. 2000 Aug;6(8):3342-53.
8
CCAAT/enhancer binding protein homologous protein-dependent death receptor 5 induction and ubiquitin/proteasome-mediated cellular FLICE-inhibitory protein down-regulation contribute to enhancement of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by dimethyl-celecoxib in human non small-cell lung cancer cells.CCAAT/增强子结合蛋白同源蛋白依赖性死亡受体5的诱导以及泛素/蛋白酶体介导的细胞FLICE抑制蛋白下调,有助于二甲基塞来昔布增强人非小细胞肺癌细胞中肿瘤坏死因子相关凋亡诱导配体诱导的凋亡。
Mol Pharmacol. 2007 Nov;72(5):1269-79. doi: 10.1124/mol.107.037465. Epub 2007 Aug 7.
9
Inhibition of COX-2 in colon cancer cell lines by celecoxib increases the nuclear localization of active p53.塞来昔布对结肠癌细胞系中COX-2的抑制作用增加了活性p53的核定位。
Cancer Res. 2003 Sep 1;63(17):5239-42.
10
In vitro model of normal, immortalized ovarian surface epithelial and ovarian cancer cells for chemoprevention of ovarian cancer.用于卵巢癌化学预防的正常、永生化卵巢表面上皮细胞和卵巢癌细胞的体外模型。
Gynecol Oncol. 2005 Aug;98(2):182-92. doi: 10.1016/j.ygyno.2005.01.051.

引用本文的文献

1
Sulindac exhibits anti-proliferative and anti-invasive effects and enhances the sensitivity to paclitaxel in ovarian cancer.舒林酸在卵巢癌中具有抗增殖和抗侵袭作用,并增强对紫杉醇的敏感性。
Front Pharmacol. 2025 Apr 30;16:1520771. doi: 10.3389/fphar.2025.1520771. eCollection 2025.
2
Cyclin D1 expression and the inhibitory effect of celecoxib on ovarian tumor growth in vivo.细胞周期蛋白 D1 的表达及塞来昔布对体内卵巢肿瘤生长的抑制作用。
Int J Mol Sci. 2010 Oct 19;11(10):3999-4013. doi: 10.3390/ijms11103999.
3
Use of nonsteroidal antiinflammatory agents and incidence of ovarian cancer in 2 large prospective cohorts.
两大前瞻性队列中非甾体抗炎药的使用与卵巢癌发病率
Am J Epidemiol. 2009 Jun 1;169(11):1378-87. doi: 10.1093/aje/kwp062. Epub 2009 Apr 2.